Litigation Details for CF Advance Corp. v. Thrasher (M.D. Fla. 2018)
✉ Email this page to a colleague
CF Advance Corp. v. Thrasher (M.D. Fla. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-10-19 |
Court | District Court, M.D. Florida | Date Terminated | |
Cause | 28:1338 Patent Infringement | Assigned To | Carlos Eduardo Mendoza |
Jury Demand | None | Referred To | Daniel C. Irick |
Parties | CF ADVANCE CORP.; ZACHARIAH THOMAS THRASHER | ||
Patents | 10,005,954; 7,462,758; 8,003,627; 8,034,755; 8,586,038; 8,754,011; 9,211,291; 9,757,471; 9,758,586 | ||
Attorneys | Aaron T. Olejniczak; Andrew Scott Rapacke; Christopher R. Liro; Louis Raymond Gigliotti , Jr.; Mark Alexander Goldstein | ||
Firms | Andrus Intellectual Property Law LLP; Louis R. Gigliotti, Jr., PA; The Rapacke Law Group, P.A. | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CF Advance Corp. v. Thrasher
Biologic Drugs cited in CF Advance Corp. v. Thrasher
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for CF Advance Corp. v. Thrasher (M.D. Fla. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-05-26 | 81 | Amended Complaint | Accordingly, claim 5 in the ’291 patent is the only original claim found patentable by the USPTO; original… 6 stand rejected as not patentable. 27. Claim 5 of the ’291 patent requires, among other limitations…substantial new question of patentability affecting claims 1-5 of United States Patent Number 9,744,627 is raised…014,212 rejecting the patentability of all original claims (1-5) in the ’627 patent. 32. On March… found patentable by the USPTO; original claims 1-5 all stand rejected as not patentable. 35 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |